meditech's blog

The global MedTech CMO (Contract Manufacturing Organization) market is experiencing robust growth, projected at a healthy compound annual growth rate (CAGR) of 11%. This growth is driven by increased outsourcing by Original Equipment Manufacturers (OEMs), heightened demand in segments such as Drug Delivery and Minimally Invasive Surgery (MIS), and the burgeoning burden of chronic diseases. Additionally, the rising demand for cost-effective medical devices and the increasing complexity of regulatory requirements further propel the MedTech CMO market forward.

The global Cell Analysis Market is set to experience a robust growth rate of 10-11% by the year 2028. Key factors contributing to this growth include the escalating demand for cell-based assays in drug discovery, increased funding for cell-based research, a surge in drug discovery activities, a rising prevalence of chronic diseases, and ongoing technological advancements in the field of cell analysis.